Home LiteratureArticle Details
PMID: 29540172 Published · epublish English Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

How structural elements evolving from bacterial to human SLC6 transporters enabled new functional properties.

BMC biology ·Vol. 16 ·No. 1 ·2018-00-14 ·Pages 31

Razavi AM, Khelashvili G, Weinstein H

Abstract

Much of the structure-based mechanistic understandings of the function of SLC6A neurotransmitter transporters emerged from the study of their bacterial LeuT-fold homologs. It has become evident, however, that structural differences such as the long N- and C-termini of the eukaryotic neurotransmitter transporters are involved in an expanded set of functional properties to the eukaryotic transporters. These functional properties are not shared by the bacterial homologs, which lack the structural elements that appeared later in evolution. However, mechanistic insights into some of the measured functional properties of the eukaryotic transporters that have been suggested to involve these structural elements are sparse or merely descriptive. To learn how the structural elements added in evolution enable mechanisms of the eukaryotic transporters in ways not shared with their bacterial LeuT-like homologs, we focused on the human dopamine transporter (hDAT) as a prototype. We present the results of a study employing large-scale molecular dynamics simulations and comparative Markov state model analysis of experimentally determined properties of the wild-type and mutant hDAT constructs. These offer a quantitative outline of mechanisms in which a rich spectrum of interactions of the hDAT N-terminus and C-terminus contribute to the regulation of transporter function (e.g., by phosphorylation) and/or to entirely new phenotypes (e.g., reverse uptake (efflux)) that were added in evolution. The findings are consistent with the proposal that the size of eukaryotic neurotransmitter transporter termini increased during evolution to enable more functions (e.g., efflux) not shared with the bacterial homologs. The mechanistic explanations for the experimental findings about the modulation of function in DAT, the serotonin transporter, and other eukaryotic transporters reveal separate roles for the distal and proximal segments of the much larger N-terminus in eukaryotic transporters compared to the bacterial ones. The involvement of the proximal and distal segments - such as the role of the proximal segment in sustaining transport in phosphatidylinositol 4,5-bisphosphate-depleted membranes and of the distal segment in modulating efflux - may represent an evolutionary adaptation required for the function of eukaryotic transporters expressed in various cell types of the same organism that differ in the lipid composition and protein complement of their membrane environment.

Keywords
Dopamine transport Evolutionary gain of function Markov state models Molecular dynamics simulations Regulation by PIP2 Regulation by phosphorylation Reverse transport SERT SLC6 neurotransmitter transporters posttranslational modifications
MeSH Terms
Bacterial Proteins/chemistry,metabolism Evolution, Molecular Humans Molecular Dynamics Simulation Neurotransmitter Transport Proteins/chemistry,metabolism Phosphorylation Protein Conformation Protein Processing, Post-Translational
Chemicals
Bacterial Proteins Neurotransmitter Transport Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Razavi Asghar M
Department of Physiology and Biophysics, Weill Cornell Medical College of Cornell University, New York, NY, 10065, USA.
Khelashvili George
Department of Physiology and Biophysics, Weill Cornell Medical College of Cornell University, New York, NY, 10065, USA. | Institute for Computational Biomedicine, Weill Cornell Medical College of Cornell University, New York, NY, 10065, USA.
Weinstein Harel ORCID
Department of Physiology and Biophysics, Weill Cornell Medical College of Cornell University, New York, NY, 10065, USA. haw2002@med.cornell.edu. | Institute for Computational Biomedicine, Weill Cornell Medical College of Cornell University, New York, NY, 10065, USA. haw2002@med.cornell.edu.
References (79)
79 references, click to expand
  1. The solute carrier 6 family of transporters.
    Br J Pharmacol. 2012 Sep;167(2):256-78 PMID: 22519513
  2. The mechanism of a neurotransmitter:sodium symporter--inward release of Na+ and substrate is triggered by substrate in a second binding site.
    Mol Cell. 2008 Jun 20;30(6):667-77 PMID: 18570870
  3. A Markov State-based Quantitative Kinetic Model of Sodium Release from the Dopamine Transporter.
    Sci Rep. 2017 Jan 06;7:40076 PMID: 28059145
  4. Reciprocal Phosphorylation and Palmitoylation Control Dopamine Transporter Kinetics.
    J Biol Chem. 2015 Nov 27;290(48):29095-105 PMID: 26424792
  5. Everything you wanted to know about Markov State Models but were afraid to ask.
    Methods. 2010 Sep;52(1):99-105 PMID: 20570730
  6. Rare autism-associated variants implicate syntaxin 1 (STX1 R26Q) phosphorylation and the dopamine transporter (hDAT R51W) in dopamine neurotransmission and behaviors.
    EBioMedicine. 2015 Feb;2(2):135-146 PMID: 25774383
  7. Microseconds simulations reveal a new sodium-binding site and the mechanism of sodium-coupled substrate uptake by LeuT.
    J Biol Chem. 2015 Jan 2;290(1):544-55 PMID: 25381247
  8. Dopamine Transporter Amino and Carboxyl Termini Synergistically Contribute to Substrate and Inhibitor Affinities.
    J Biol Chem. 2017 Jan 27;292(4):1302-1309 PMID: 27986813
  9. The N terminus of monoamine transporters is a lever required for the action of amphetamines.
    J Biol Chem. 2010 Apr 2;285(14):10924-38 PMID: 20118234
  10. A coarse graining method for the identification of transition rates between molecular conformations.
    J Chem Phys. 2007 Jan 14;126(2):024103 PMID: 17228939
  11. Spontaneous inward opening of the dopamine transporter is triggered by PIP2-regulated dynamics of the N-terminus.
    ACS Chem Neurosci. 2015 Nov 18;6(11):1825-37 PMID: 26255829
  12. Transient formation of water-conducting states in membrane transporters.
    Proc Natl Acad Sci U S A. 2013 May 7;110(19):7696-701 PMID: 23610412
  13. Membrane cholesterol access into a G-protein-coupled receptor.
    Nat Commun. 2017 Feb 21;8:14505 PMID: 28220900
  14. SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking.
    Transl Psychiatry. 2014 Oct 14;4:e464 PMID: 25313507
  15. Direct PIP2 binding mediates stable oligomer formation of the serotonin transporter.
    Nat Commun. 2017 Jan 19;8:14089 PMID: 28102201
  16. The N Terminus Specifies the Switch between Transport Modes of the Human Serotonin Transporter.
    J Biol Chem. 2017 Mar 3;292(9):3603-3613 PMID: 28104804
  17. A comprehensive structure-based alignment of prokaryotic and eukaryotic neurotransmitter/Na+ symporters (NSS) aids in the use of the LeuT structure to probe NSS structure and function.
    Mol Pharmacol. 2006 Nov;70(5):1630-42 PMID: 16880288
  18. How LeuT shapes our understanding of the mechanisms of sodium-coupled neurotransmitter transporters.
    J Physiol. 2014 Mar 1;592(5):863-9 PMID: 23878376
  19. X-ray structure of dopamine transporter elucidates antidepressant mechanism.
    Nature. 2013 Nov 7;503(7474):85-90 PMID: 24037379
  20. Cocaine receptors on dopamine transporters are related to self-administration of cocaine.
    Science. 1987 Sep 4;237(4819):1219-23 PMID: 2820058
  21. Identification of slow molecular order parameters for Markov model construction.
    J Chem Phys. 2013 Jul 7;139(1):015102 PMID: 23822324
  22. Dopamine transporter phosphorylation site threonine 53 regulates substrate reuptake and amphetamine-stimulated efflux.
    J Biol Chem. 2012 Aug 24;287(35):29702-12 PMID: 22722938
  23. Atypical dopamine efflux caused by 3,4-methylenedioxypyrovalerone (MDPV) via the human dopamine transporter.
    J Chem Neuroanat. 2017 Oct;83-84:69-74 PMID: 28163218
  24. Mechanisms of dopamine transporter regulation in normal and disease states.
    Trends Pharmacol Sci. 2013 Sep;34(9):489-96 PMID: 23968642
  25. Reactive flux and folding pathways in network models of coarse-grained protein dynamics.
    J Chem Phys. 2009 May 28;130(20):205102 PMID: 19485483
  26. Improvements in Markov State Model Construction Reveal Many Non-Native Interactions in the Folding of NTL9.
    J Chem Theory Comput. 2013 Apr 9;9(4):2000-2009 PMID: 23750122
  27. Complete mapping of substrate translocation highlights the role of LeuT N-terminal segment in regulating transport cycle.
    PLoS Comput Biol. 2014 Oct 09;10(10):e1003879 PMID: 25299050
  28. Neurotransmitter transporters: molecular function of important drug targets.
    Trends Pharmacol Sci. 2006 Jul;27(7):375-83 PMID: 16762425
  29. Slow unfolded-state structuring in Acyl-CoA binding protein folding revealed by simulation and experiment.
    J Am Chem Soc. 2012 Aug 1;134(30):12565-77 PMID: 22747188
  30. Allosteric Mechanisms of Molecular Machines at the Membrane: Transport by Sodium-Coupled Symporters.
    Chem Rev. 2016 Jun 8;116(11):6552-87 PMID: 26892914
  31. MSMBuilder2: Modeling Conformational Dynamics at the Picosecond to Millisecond Scale.
    J Chem Theory Comput. 2011 Oct 11;7(10):3412-3419 PMID: 22125474
  32. MDTraj: A Modern Open Library for the Analysis of Molecular Dynamics Trajectories.
    Biophys J. 2015 Oct 20;109 (8):1528-32 PMID: 26488642
  33. Computational modeling of the N-terminus of the human dopamine transporter and its interaction with PIP2 -containing membranes.
    Proteins. 2015 May;83(5):952-69 PMID: 25739722
  34. Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood.
    Brain. 2014 Apr;137(Pt 4):1107-19 PMID: 24613933
  35. PIP2 regulates psychostimulant behaviors through its interaction with a membrane protein.
    Nat Chem Biol. 2014 Jul;10 (7):582-589 PMID: 24880859
  36. A mechanism for intracellular release of Na+ by neurotransmitter/sodium symporters.
    Nat Struct Mol Biol. 2014 Nov;21(11):1006-12 PMID: 25282149
  37. Mechanisms of Lipid Scrambling by the G Protein-Coupled Receptor Opsin.
    Structure. 2018 Feb 6;26(2):356-367.e3 PMID: 29290486
  38. Scalable molecular dynamics with NAMD.
    J Comput Chem. 2005 Dec;26(16):1781-802 PMID: 16222654
  39. De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder.
    Mol Psychiatry. 2013 Dec;18(12):1315-23 PMID: 23979605
  40. Functional mechanisms of neurotransmitter transporters regulated by lipid-protein interactions of their terminal loops.
    Biochim Biophys Acta. 2015 Sep;1848(9):1765-74 PMID: 25847498
  41. Thermodynamic Coupling Function Analysis of Allosteric Mechanisms in the Human Dopamine Transporter.
    Biophys J. 2018 Jan 9;114(1):10-14 PMID: 29153319
  42. Complete protein-protein association kinetics in atomic detail revealed by molecular dynamics simulations and Markov modelling.
    Nat Chem. 2017 Oct;9(10 ):1005-1011 PMID: 28937668
  43. Monoamine neurotransmitter disorders--clinical advances and future perspectives.
    Nat Rev Neurol. 2015 Oct;11(10):567-84 PMID: 26392380
  44. Stochastic steps in secondary active sugar transport.
    Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):E3960-6 PMID: 27325773
  45. Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport.
    Neuron. 2006 Aug 17;51(4):417-29 PMID: 16908408
  46. Independent component analysis: algorithms and applications.
    Neural Netw. 2000 May-Jun;13(4-5):411-30 PMID: 10946390
  47. The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants.
    Proc Natl Acad Sci U S A. 2014 Nov 4;111(44):E4779-88 PMID: 25331903
  48. Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation.
    J Neurosci. 2012 Apr 18;32(16):5385-97 PMID: 22514303
  49. Computational characterization of structural dynamics underlying function in active membrane transporters.
    Curr Opin Struct Biol. 2015 Apr;31:96-105 PMID: 25913536
  50. VMD: visual molecular dynamics.
    J Mol Graph. 1996 Feb;14(1):33-8, 27-8 PMID: 8744570
  51. Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters.
    Nature. 2005 Sep 8;437(7056):215-23 PMID: 16041361
  52. Mechanisms of neurotransmitter release by amphetamines: a review.
    Prog Neurobiol. 2005 Apr;75(6):406-33 PMID: 15955613
  53. Slow dynamics in protein fluctuations revealed by time-structure based independent component analysis: the case of domain motions.
    J Chem Phys. 2011 Feb 14;134(6):065101 PMID: 21322734
  54. Dynamic and Kinetic Elements of µ-Opioid Receptor Functional Selectivity.
    Sci Rep. 2017 Sep 12;7(1):11255 PMID: 28900175
  55. Modeling and dynamics of the inward-facing state of a Na+/Cl- dependent neurotransmitter transporter homologue.
    PLoS Comput Biol. 2010 Aug 26;6(8):null PMID: 20865057
  56. Phosphorylation of dopamine transporter serine 7 modulates cocaine analog binding.
    J Biol Chem. 2013 Jan 4;288(1):20-32 PMID: 23161550
  57. Molecular simulation of ab initio protein folding for a millisecond folder NTL9(1-39).
    J Am Chem Soc. 2010 Feb 10;132(5):1526-8 PMID: 20070076
  58. Structure and regulatory interactions of the cytoplasmic terminal domains of serotonin transporter.
    Biochemistry. 2014 Aug 26;53(33):5444-60 PMID: 25093911
  59. Amphetamine actions at the serotonin transporter rely on the availability of phosphatidylinositol-4,5-bisphosphate.
    Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):11642-7 PMID: 23798435
  60. Chloride binding site of neurotransmitter sodium symporters.
    Proc Natl Acad Sci U S A. 2013 May 21;110(21):8489-94 PMID: 23641004
  61. N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux.
    PLoS Biol. 2004 Mar;2(3):E78 PMID: 15024426
  62. Molecular Mechanism of Dopamine Transport by Human Dopamine Transporter.
    Structure. 2015 Nov 3;23 (11):2171-81 PMID: 26481814
  63. Flotillin-1 is essential for PKC-triggered endocytosis and membrane microdomain localization of DAT.
    Nat Neurosci. 2011 Apr;14(4):469-77 PMID: 21399631
  64. Cloud-based simulations on Google Exacycle reveal ligand modulation of GPCR activation pathways.
    Nat Chem. 2014 Jan;6(1):15-21 PMID: 24345941
  65. Anomalous dopamine release associated with a human dopamine transporter coding variant.
    J Neurosci. 2008 Jul 9;28(28):7040-6 PMID: 18614672
  66. ACEMD: Accelerating Biomolecular Dynamics in the Microsecond Time Scale.
    J Chem Theory Comput. 2009 Jun 9;5(6):1632-9 PMID: 26609855
  67. Missense dopamine transporter mutations associate with adult parkinsonism and ADHD.
    J Clin Invest. 2014 Jul;124(7):3107-20 PMID: 24911152
  68. Complex pathways in folding of protein G explored by simulation and experiment.
    Biophys J. 2014 Aug 19;107(4):947-55 PMID: 25140430
  69. Phosphorylation mechanisms in dopamine transporter regulation.
    J Chem Neuroanat. 2017 Oct;83-84:10-18 PMID: 27836487
  70. Evaluating the effects of cutoffs and treatment of long-range electrostatics in protein folding simulations.
    PLoS One. 2012;7(6):e39918 PMID: 22768169
  71. Membrane lipids are key modulators of the endocannabinoid-hydrolase FAAH.
    Biochem J. 2014 Feb 1;457(3):463-72 PMID: 24215562
  72. Simple few-state models reveal hidden complexity in protein folding.
    Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):17807-13 PMID: 22778442
  73. Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux.
    Mol Pharmacol. 2008 Oct;74(4):1101-8 PMID: 18617632
  74. How addictive drugs disrupt presynaptic dopamine neurotransmission.
    Neuron. 2011 Feb 24;69(4):628-49 PMID: 21338876
  75. Two Na+ Sites Control Conformational Change in a Neurotransmitter Transporter Homolog.
    J Biol Chem. 2016 Jan 15;291(3):1456-71 PMID: 26582198
  76. Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder.
    J Neurosci. 2010 Apr 28;30(17):6048-57 PMID: 20427663
  77. Markov state models of biomolecular conformational dynamics.
    Curr Opin Struct Biol. 2014 Apr;25:135-44 PMID: 24836551
  78. Markov models of molecular kinetics: generation and validation.
    J Chem Phys. 2011 May 7;134(17):174105 PMID: 21548671
  79. MSMBuilder: Statistical Models for Biomolecular Dynamics.
    Biophys J. 2017 Jan 10;112(1):10-15 PMID: 28076801
Article Info
Journal
BMC biology
Abbr.
BMC Biol
ISSN
1741-7007
Published
2018-00-14
Epub
2018-00-14
Pages
31
Language
English
Region
England
NLM ID
101190720
PMCID
PMC5852957
Subset
IM
Grants
NIGMS NIH HHS · U54 GM087519 · United States
NIDA NIH HHS · R01 DA041510 · United States
NIDA NIH HHS · P01 DA012408 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com